A webinar on Thursday, December 12 from Noon to 1 pm ET will focus on how companies are meeting these challenges. The post How Can Employers Give Staff the Best Care Amidst Rising Healthcare Costs? appeared first on MedCity News.
CHARLESTON, W.Va. — More than three years have passed since federal health officials arrived in central Appalachia to assess an alarming outbreak of HIV spread mostly between people who inject opioids or methamphetamine. Infectious disease experts from the Centers for Disease Control and Prevention made a list of recommendations following their visit, including one to…
By KIM BELLARD On the heels of the disastrous floods in Texas, days away from the Hurricane Katrina twenty year anniversary, and with Hurricane Erin almost becoming another Hurricane Sandy, the dedicated employees at FEMA are worried. Very worried. They’ve got a President who repeatedly has called to dismantle the agency, a DHS Secretary who…
KFF Health News Nevada correspondent Jazmin Orozco Rodriguez discussed the potential impact of Medicaid cuts on rural hospitals on KNPR’s “State of Nevada” on July 17. Click here to hear Orozco Rodriguez on “State of Nevada.” Read Orozco Rodriguez’s “‘One Big Beautiful Bill’ Would Batter Rural Hospital Finances, Researchers Say.” KFF Health News chief Washington…
Following evidence showing that bacterial vaginosis affects both men and women, Wisp has launched a male BV partner treatment. The post Wisp Unveils Male Bacterial Vaginosis Partner Treatment appeared first on MedCity News.
At the MedCity INVEST conference May 20-21 in Chicago, the startups will take part in the Pitch Perfect contest, pitching their technology and services to investor judges. The post 6 Care Navigation/Care Coordination Startups Aimed at Consumers/Employers to Watch appeared first on MedCity News.
Johnson & Johnson’s agreement to acquire Intra-Cellular Therapies brings Caplyta, which is projected to become a blockbuster seller across several neurological indications. In other M&A news, GSK and Eli Lilly each struck deals to fill their cancer drug pipelines. The post J&J Bolsters Its Prospects in Brain Health With $14B Buyout of Intra-Cellular Therapies appeared…
Akero Therapeutics reported that at 96 weeks, 39% of patients who received the 50 mg dose of efruxifermin achieved improvement in fibrosis, or liver scarring, caused by the fatty liver disease MASH. This study previously failed to achieve statistically significant improvement at 36 weeks, but Akero executives say the latest results show that longer dosing…
Nema Health has cracked the code on PTSD and has an amazing study showing that their technique of intensive cognitive processing therapy is over 99% effective in flat out curing it in under a month. CEO psychiatrist Sofia Noori took me through what PTSD is, a full demo of how their solution works, and showed…
McKesson is paying $2.49 billion in cash for a controlling interest in Florida Cancer Specialists’ management services organization